In vivo efficacy of Trachyspermum ammi anticalcifying protein in urolithiatic rat model

Journal of Ethnopharmacology

Volumn 126, Issue 3, 2009, Pages 459-462

  Kaur, Tanzeer ^a   Bijarnia, Rakesh K ^a   Singla, Surinder K ^b   Tandon, Chanderdeep ^a  

^a JAYPEE UNIVERSITY OF INFORMATION TECHNOLOGY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Antilithiatic; Inhibitory proteins; Trachyspermum ammi; Urolithiasis

Indexed keywords

AMMONIUM CHLORIDE; ANTICALCIFYING PROTEIN; CALCIUM OXALATE; ETHYLENE GLYCOL; OXALIC ACID; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; CONTROLLED STUDY; DRUG DESIGN; DRUG EFFICACY; IN VIVO STUDY; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY PARENCHYMA; MALE; MEDICINAL PLANT; NONHUMAN; PLANT SEED; RAT; TRACHYSPERMUM AMMI; UROLITHIASIS;

ANIMALS; APIACEAE; CALCINOSIS; DISEASE MODELS, ANIMAL; MALE; PLANT PROTEINS; RATS; RATS, WISTAR; SEEDS; UROLITHIASIS;

APIACEAE; RATTUS; TRACHYSPERMUM AMMI;

EID: 70449656946     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.09.015     Document Type: Article

References (30)

1. Ahsan S.K., Shah A.H., Tanira M.O.M., Ahmad M.S., Tariq M., and Ageel M. Studies on some herbal drugs used against kidney stones in Saudi Folk medicine. Fitoterapia 61 (1990) 435-438
2. Balbaa S.I., Hilal S.H., and Hagga M.Y. The volatile oil from herb and fruit of Carum copticum at different stages of growth. Planta Medica 23 (1993) 312-320
3. Bijarnia R.K., Kaur T., Aggarwal K., Singla S.K., and Tandon C. Modulatory effects of N-acetylcysteine on hyperoxaluric manifestations in rat kidney. Food and Chemical Toxicology 46 (2008) 2274-2278
4. Bonsnes R.W., and Taussky H.H. Colorimetric determination of creatinine by Jaffe's reaction. Journal of Biological Chemistry 158 (1945) 581-589
5. Bown D. Encyclopaedia of Herbs and their Uses (1995), Dorling Kindersley Press, London
6. Cao Z.G., Liu J.H., Radman A.M., Wu J.Z., Ying C.P., and Zhou S.W. An experimental study of effect of different extracts of Alisma orientalis on urinary calcium oxalate stones formation in rats. Zhongguo Zhong Yao Za Zhi 28 (2003) 1072-1107
7. Chialva F., Monguzzi F., Manitto P., and Akgul A. Essential oil constituents of Trachyspermum ammi (L.) link fruits. Journal of Essential Oil Research 51 (1993) 105-106
8. Chopra R.N., Nayar S.L., and Chopra I.C. Glossary of Indian Medicinal Plants (1986), Council of Scientific and Industrial Research, New Delhi
9. Choudhary S., Riyazuddin A., Kanjilal P.B., and Leclercq P.A. Composition of seed oil of Trachyspermum ammi (L.) Sprague from Northeast India. Journal of Essential Oil Research 10 (1998) 588-590
10. Green M.L., Freel R.W., and Hatch M. Lipid peroxidation is not the underlying cause of renal injury in hyperoxaluric rats. Kidney International 68 (2005) 2629-2638
11. Grover P.K., Thurgood L.A., and Ryall R.L. Effect of urine fractionation on attachment of calcium oxalate crystals to renal epithelial cells: implications for studying renal calculogenesis. American Journal of Physiology and Renal Physiology 292 (2007) 1396-1403
12. Hackett R.L., Shevock P.N., and Khan S.R. Cell injury associated calcium oxalate crystalluria. Journal of Urology 144 (1990) 1535-1538
13. Herrmann U., Schwille P.O., and Kuch P. Crystalluria determined by polarization microscopy. Urological Research 19 (1991) 151-158
14. Kantor F.S. Fibrinogen precipitation by streptococcal M protein. II. Renal lesions induced by intravenous injection of M protein into mice and rats. Journal of Experimental Medicine 121 (1965) 849-859
15. Kaur T., Bijarnia R.K., Singla S.K., and Tandon C. Purification and characterization of an anticalcifying protein from the seeds of Trachyspermum ammi (L.). Protein and Peptide Letters 16 (2009) 173-181
16. Khan S.R., Glenton P.A., and Byer K.J. Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-l-proline. Kidney International 70 (2006) 914-923
17. Khan S.R., Shevock P.N., and Hackett R.L. Acute hyperoxaluria, renal injury and calcium oxalate urolithiasis. Journal of Urology 147 (1992) 226-230
18. Kumar V., Yu S., Farell G., Toback F.G., and Lieske J.C. Renal epithelial cells constitutively produce a protein that blocks adhesion of crystals to their surface. American Journal of Physiology and Renal Physiology 287 (2004) 373-383
19. Mandel N.S., and Mandel G.S. Urinary tract stone disease in United States veteran population. II. Geographical analysis of variation in composition. Journal of Urology 142 (1989) 1516-1521
20. Marsh W.H., Fingerhut B., and Miller H. Alternative and manual direct methods for the determination of blood urea. Clinical Chemistry 11 (1965) 624-627
21. Robertson W.G., Peacock M., and Nordin D.E.C. Calcium crystalluria in recurrent renal stone formers. Lancet 2 (1969) 21-23
22. Schroder F.H. Association of calcium oxalate monohydrate crystals with MDCK cells. Kidney International 48 (1995) 129-138
23. Singh V.K., Singh S., and Singh D.K. Recent Progress in Medicinal Plants (2003), Stadium Press, Houston, USA pp. 321-353
24. Terlecki R.P., and Triest J.A. A contemporary evaluation of the auditory hazard of extracorporeal shock wave lithotripsy. Urology 70 (2007) 898-899
25. Thamilselvan S., and Khan S.R. Oxalate and calcium oxalate crystals are injurious to renal epithelial cells: results of in vivo and in vitro studies. Journal of Nephrology 11 (1998) 66-69
26. Tsujihata M., Miyake O., Yoshimura K., Kakimoto K.I., Takahara S., and Okuyama A. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis. Journal of Urology 164 (2000) 1718-1723
27. Verkoelen C.F., van der Boom B.G., Houtsmuller A.B., Schröder F.H., and Romijn J.C. Increased calcium oxalate monohydrate crystal binding to injured renal tubular epithelial cells in culture. American Journal of Physiology 274 (1998) 958-965
28. Worcester E.M., Parks J.H., Evan A.P., and Coe F.L. Renal function in patients with nephrolithiasis. Journal of Urology 176 (2006) 600-603
29. Yamagata M., Ozono K., Hashimoto Y., Miyauchi Y., Kondou H., and Michigami T. Intraperitoneal administration of recombinant receptor-associated protein causes phosphaturia via an alteration in subcellular distribution of the renal sodium phosphate co-transporter. Journal of American Society of Nephrology 16 (2005) 2338-2345
30. Yamaguchi S., Wiessner J.H., Hasegawa A.T., Hung L.Y., Mandel G.S., and Mandel N.S. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions. International Journal of Urology 12 (2005) 290-298